In this study, we found that patients with high expression of PLCD3 have shorter overall survival and higher levels of PLCD3 expression in tumor tissue, which indicates that PLCD3 plays a role as an oncogene in PDAC. The gene discussed is PLCD3; the disease is neoplasm.